320 related articles for article (PubMed ID: 17367814)
1. Multiple sclerosis: is there neurodegeneration independent from inflammation?
Lassmann H
J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
[TBL] [Abstract][Full Text] [Related]
2. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
Inglese M; Benedetti B; Filippi M
J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
[TBL] [Abstract][Full Text] [Related]
3. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
Hauser SL; Oksenberg JR
Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
[TBL] [Abstract][Full Text] [Related]
4. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H
Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
Charil A; Filippi M
J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
[TBL] [Abstract][Full Text] [Related]
6. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inflammation induced tissue injury in multiple sclerosis.
Lassmann H
J Neurol Sci; 2008 Nov; 274(1-2):45-7. PubMed ID: 18495163
[TBL] [Abstract][Full Text] [Related]
8. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
[TBL] [Abstract][Full Text] [Related]
9. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
10. Protecting axons in multiple sclerosis.
Wilkins A; Scolding N
Mult Scler; 2008 Sep; 14(8):1013-25. PubMed ID: 18632772
[TBL] [Abstract][Full Text] [Related]
11. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
Owens T
Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
13. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.
Imitola J; Chitnis T; Khoury SJ
Arch Neurol; 2006 Jan; 63(1):25-33. PubMed ID: 16401734
[TBL] [Abstract][Full Text] [Related]
14. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
15. [The interest of multiple sclerosis attacks. Physiopathology and therapy].
de Andrés C
Rev Neurol; 2003 Jun 1-15; 36(11):1058-64. PubMed ID: 12808503
[TBL] [Abstract][Full Text] [Related]
16. Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
Ge Y
Top Magn Reson Imaging; 2006 Aug; 17(4):295-306. PubMed ID: 17415002
[TBL] [Abstract][Full Text] [Related]
17. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
18. Pathology and disease mechanisms in different stages of multiple sclerosis.
Lassmann H
J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
Filippi M; Agosta F
Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
[TBL] [Abstract][Full Text] [Related]
20. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
